Clinical Trials
Trust the experts at PIH Health to help you decide if a heart-related clinical trial is right for you. Our physicians can provide access and guidance to those who qualify.
What is a Clinical Trial?
A clinical trial is a type of research that studies new treatment options by evaluating the effect on health outcomes in participants.
Taking Patients from Discovery to Recovery
Through innovative and cutting-edge cardiovascular research at PIH Health, many new treatment opportunities and technologies are made available to our patients. Providing medications, devices, and patient therapies, that may otherwise not be available, establishes PIH Health as a recognized leader in providing excellent care for our communities.
Benefits and Value to You:
- Access to advanced cardiovascular treatments not widely available
- Expert medical care at a leading healthcare organization
- Help others by contributing to medical research
- Play a more active role in your healthcare
- Additional specialists and healthcare team
Making Tomorrow's Medicine Today
We are currently participating in over 70 research trials in various clinical areas including oncology, stroke, cardiovascular, neonatal, and podiatry.
To learn more, talk to your doctor or email us at ClinicalTrials@PIHHealth.org.
Clinical Trials for Heart Disease
• APOLLO
Transcatheter mitral valve replacement for patients with moderate to severe symptomatic mitral regurgitation
• CLASP IID/IIF
Transcatheter valve repair system for patients with moderate to severe mitral regurgitation
• ELEGANCE Registry
Treatment of peripheral artery disease (PAD) with a drug eluting device
• EMPOWER CAD
Equity in modifying plaque of women with undertreated calcified coronary artery disease
• ENCIRCLE
Transcatheter mitral valve replacement for patients with moderate to severe symptomatic mitral regurgitation
• FACT-CRT
Cardiac re-synchronization therapy (CRT) for the treatment of heart failure
• HEAL-LAA
Treatment to reduce the risk of thromboembolism in non-valvular atrial fibrillation with a left atrial appendage closure device
• JETi Registry
Jet enhanced thrombectomy intervention for the treatment of peripheral vascular disease
• Librexia AF
Investigational drug study for the prevention of cardioembolic events in patients with atrial fibrillation
• Victorian-2 Prevent
Investigational drug study for the prevention of future cardiovascular events in people with documented cardiovascular disease (CVD)
Please call 562.698.0811 Ext. 12930 for more information